| Year |
Citation |
Score |
| 2020 |
DeZern AE, Zahurak ML, Symons HJ, Cooke KR, Rosner GL, Gladstone DE, Huff CA, Swinnen LJ, Imus P, Borrello I, Wagner-Johnston N, Ambinder RF, Luznik L, Bolaños-Meade J, Fuchs EJ, et al. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide. Blood Advances. 4: 1770-1779. PMID 32343796 DOI: 10.1182/Bloodadvances.2020001729 |
0.32 |
|
| 2018 |
Henderson NC, Louis TA, Rosner GL, Varadhan R. Individualized treatment effects with censored data via fully nonparametric Bayesian accelerated failure time models. Biostatistics (Oxford, England). PMID 30052809 DOI: 10.1093/Biostatistics/Kxy028 |
0.311 |
|
| 2014 |
Paller CJ, Rudek MA, Antonarakis ES, Eisenberger MA, Hammers HJ, Zhou XC, Dowling D, King S, Hudock S, Denmeade SR, Wagner WD, Rosner GL, Hudson T, Carducci MA. A phase I trial of muscadine grape skin in men with biochemically recurrent prostate cancer. Journal of Clinical Oncology. 32: 263-263. DOI: 10.1200/Jco.2014.32.4_Suppl.263 |
0.365 |
|
| 2010 |
Hennessey VG, Rosner GL, Bast RC, Chen MY. A Bayesian approach to dose-response assessment and synergy and its application to in vitro dose-response studies. Biometrics. 66: 1275-83. PMID 20337630 DOI: 10.1111/J.1541-0420.2010.01403.X |
0.335 |
|
| 2009 |
Eng C, Chang GJ, Das P, Rodriguez-Bigas M, Skibber JM, Qiao W, Rosner GL, Ukegbu LT, Wolff RA, Crane CH. Phase II study of capecitabine and oxaliplatin with concurrent radiation therapy (XELOX-XRT) for squamous cell carcinoma of the anal canal. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4116. PMID 27961220 DOI: 10.1200/Jco.2009.27.15_Suppl.4116 |
0.316 |
|
| 2009 |
Hoskins JM, Rosner GL, Ratain MJ, McLeod HL, Innocenti F. Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan. Pharmacogenomics. 10: 1139-46. PMID 19604089 DOI: 10.2217/Pgs.09.35 |
0.341 |
|
| 2009 |
De Iorio M, Johnson WO, Müller P, Rosner GL. Bayesian nonparametric nonproportional hazards survival modeling. Biometrics. 65: 762-71. PMID 19210742 DOI: 10.1111/J.1541-0420.2008.01166.X |
0.353 |
|
| 2008 |
Davies SM, Borowitz MJ, Rosner GL, Ritz K, Devidas M, Winick N, Martin PL, Bowman P, Elliott J, Willman C, Das S, Cook EH, Relling MV. Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 111: 2984-90. PMID 18182569 DOI: 10.1182/Blood-2007-09-114082 |
0.303 |
|
| 2008 |
Ding M, Rosner GL, Müller P. Bayesian optimal design for phase II screening trials. Biometrics. 64: 886-94. PMID 18162113 DOI: 10.1111/J.1541-0420.2007.00951.X |
0.535 |
|
| 2008 |
Garcia-Manero G, Yang H, Bueso-Ramos C, Ferrajoli A, Cortes J, Wierda WG, Faderl S, Koller C, Morris G, Rosner G, Loboda A, Fantin VR, Randolph SS, Hardwick JS, Reilly JF, et al. Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes. Blood. 111: 1060-6. PMID 17962510 DOI: 10.1182/Blood-2007-06-098061 |
0.356 |
|
| 2007 |
Müller P, Quintana FA, Rosner GL. Semiparametric bayesian inference for multilevel repeated measurement data. Biometrics. 63: 280-9. PMID 17447954 DOI: 10.1111/J.1541-0420.2006.00668.X |
0.31 |
|
| 2007 |
Kishi S, Cheng C, French D, Pei D, Das S, Cook EH, Hijiya N, Rizzari C, Rosner GL, Frudakis T, Pui CH, Evans WE, Relling MV. Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood. 109: 4151-7. PMID 17264302 DOI: 10.1182/Blood-2006-10-054528 |
0.305 |
|
| 2006 |
Garcia-Manero G, Kantarjian HM, Sanchez-Gonzalez B, Yang H, Rosner G, Verstovsek S, Rytting M, Wierda WG, Ravandi F, Koller C, Xiao L, Faderl S, Estrov Z, Cortes J, O'brien S, et al. Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia. Blood. 108: 3271-9. PMID 16882711 DOI: 10.1182/Blood-2006-03-009142 |
0.36 |
|
| 2006 |
Ratain MJ, Eisen T, Stadler WM, Flaherty KT, Kaye SB, Rosner GL, Gore M, Desai AA, Patnaik A, Xiong HQ, Rowinsky E, Abbruzzese JL, Xia C, Simantov R, Schwartz B, et al. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2505-12. PMID 16636341 DOI: 10.1200/Jco.2005.03.6723 |
0.303 |
|
| 2006 |
Lichtman SM, Hollis D, Miller AA, Rosner GL, Rhoades CA, Lester EP, Millard F, Byrd J, Cullinan SA, Rosen DM, Parise RA, Ratain MJ, Egorin MJ. Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 1846-51. PMID 16567769 DOI: 10.1200/Jco.2005.03.9289 |
0.301 |
|
| 2006 |
Garcia-Manero G, Bueso-Ramos C, Xiao L, Hoshino K, Rosner G, Pierce S, Yang H. Detection of Residual p73 DNA Methylation Predicts for Shorter Disease Free and Overall Survival in Patients (pts) with Philadelphia (Ph) Chromosome Negative Acute Lymphocytic Leukemia (ALL) in Remission. Blood. 108: 2333-2333. DOI: 10.1182/Blood.V108.11.2333.2333 |
0.301 |
|
| 2005 |
Thrall DE, LaRue SM, Yu D, Samulski T, Sanders L, Case B, Rosner G, Azuma C, Poulson J, Pruitt AF, Stanley W, Hauck ML, Williams L, Hess P, Dewhirst MW. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5206-14. PMID 16033838 DOI: 10.1158/1078-0432.Ccr-05-0091 |
0.301 |
|
| 2005 |
Stadler WM, Rosner G, Small E, Hollis D, Rini B, Zaentz SD, Mahoney J, Ratain MJ. Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3726-32. PMID 15923569 DOI: 10.1200/Jco.2005.44.150 |
0.332 |
|
| 2005 |
Peters WP, Rosner GL, Vredenburgh JJ, Shpall EJ, Crump M, Richardson PG, Schuster MW, Marks LB, Cirrincione C, Norton L, Henderson IC, Schilsky RL, Hurd DD. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2191-200. PMID 15767638 DOI: 10.1200/Jco.2005.10.202 |
0.31 |
|
| 2005 |
Garcia-Manero G, Kantarjian H, Sanchez-Gonzalez B, Verstovsek S, Ravandi F, Ryttling M, Cortes J, Yang H, Fiorentino J, Rosner G, Issa J. Results of a phase I/II study of the combination of 5-aza-2’-deoxycytidine and valproic acid in patients with acute myeloid leukemia and myelodysplastic syndrome Journal of Clinical Oncology. 23: 6544-6544. DOI: 10.1200/Jco.2005.23.16_Suppl.6544 |
0.309 |
|
| 2005 |
Yang H, Hoshino K, Xiao L, Rosner G, Garcia-Manero G. Aberrant DNA Methylation of a Cell Cycle Regulatory Pathway Composed of p73, p15 and P57kip2 Is Associated with Poor Prognosis in Adult Patients with Philadelphia Chromosome Negative Acute Lymphocytic Leukemia (ALL). Blood. 106: 481-481. DOI: 10.1182/Blood.V106.11.481.481 |
0.306 |
|
| 2005 |
Garcia-Manero G, Kantarjian H, Sanchez-Gonzalez B, Yang H, Rosner G, Verstovsek S, Rytting M, Ravandi F, Faderl S, Estrov Z, Cortes J, O’Brien S, Fiorentino J, Issa J. Final Results of a Phase I/II Study of the Combination of the Hypomethylating Agent 5-aza-2′-Deoxycytidine (DAC) and the Histone Deacetylase Inhibitor Valproic Acid (VPA) in Patients with Leukemia. Blood. 106: 408-408. DOI: 10.1182/Blood.V106.11.408.408 |
0.378 |
|
| 2005 |
Müller P, Rosner GL, De Iorio M, MacEachern S. A nonparametric Bayesian model for inference in related longitudinal studies Journal of the Royal Statistical Society. Series C: Applied Statistics. 54: 611-626. DOI: 10.1111/J.1467-9876.2005.05475.X |
0.361 |
|
| 2004 |
Miller AA, Rosner GL, Egorin MJ, Hollis D, Lichtman SM, Ratain MJ. Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8325-31. PMID 15623609 DOI: 10.1158/1078-0432.Ccr-04-1078 |
0.308 |
|
| 2004 |
Garcia-Manero G, Kantarjian H, Sanchez-Gonzalez B, Faderl S, Verstovsek S, Ravandi F, Ryttling M, Cortes J, Wierda W, Hoshino K, Yang H, Santos-Malave C, Fiorentino J, Jabbour E, Rosner G, et al. Results of a Phase I/II Study of the Combination of 5-aza-2′-Deoxycytidine (DAC) and Valproic Acid (VPA) in Patients (pts) with Leukemia. Blood. 104: 263-263. DOI: 10.1182/Blood.V104.11.263.263 |
0.34 |
|
| 2003 |
Lopes HF, Müller P, Rosner GL. Bayesian meta-analysis for longitudinal data models using multivariate mixture priors. Biometrics. 59: 66-75. PMID 12762442 DOI: 10.1111/1541-0420.00008 |
0.329 |
|
| 2002 |
Small EJ, Halabi S, Ratain MJ, Rosner G, Stadler W, Palchak D, Marshall E, Rago R, Hars V, Wilding G, Petrylak D, Vogelzang NJ. Randomized Study of Three Different Doses of Suramin Administered With a Fixed Dosing Schedule in Patients With Advanced Prostate Cancer: Results of Intergroup 0159, Cancer and Leukemia Group B 9480 Journal of Clinical Oncology. 20: 3369-3375. PMID 12177096 DOI: 10.1200/Jco.2002.10.022 |
0.363 |
|
| 2002 |
Bass AJ, Gockerman JP, Hammett E, DeCastro CM, Adams DJ, Rosner GL, Payne N, Davis P, Foster T, Moore JO, Rizzieri DA. Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2995-3000. PMID 12089230 DOI: 10.1200/Jco.2002.08.166 |
0.314 |
|
| 2002 |
Rizzieri DA, Bass AJ, Rosner GL, Gockerman JP, DeCastro CM, Petros WP, Adams DJ, Laughlin MJ, Davis P, Foster T, Jacobson R, Hurwitz H, Moore JO. Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 674-9. PMID 11821447 DOI: 10.1200/Jco.20.3.674 |
0.301 |
|
| 2001 |
Maguire PD, Samulski TV, Prosnitz LR, Jones EL, Rosner GL, Powers B, Layfield LW, Brizel DM, Scully SP, Harrelson JM, Dewhirst MW. A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 17: 283-90. PMID 11471980 DOI: 10.1080/02656730110039449 |
0.341 |
|
| 2001 |
Gandhi V, Plunkett W, Weller S, Du M, Ayres M, Rodriguez C.O. J, Ramakrishna P, Rosner GL, Hodge JP, O'Brien S, Keating MJ. Evaluation of the combination of nelarabine and fludarabine in leukemias: Clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells Journal of Clinical Oncology. 19: 2142-2152. PMID 11304766 DOI: 10.1200/Jco.2001.19.8.2142 |
0.362 |
|
| 2001 |
Braun RD, Lanzen JL, Turnage JA, Rosner G, Dewhirst MW. Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in Fischer 344 rats. Radiation Research. 155: 724-33. PMID 11302770 DOI: 10.1667/0033-7587(2001)155[0724:Eotibc]2.0.Co;2 |
0.315 |
|
| 2000 |
Thrall DE, Rosner GL, Azuma C, Larue SM, Case BC, Samulski T, Dewhirst MW. Using units of CEM 43 degrees C T90, local hyperthermia thermal dose can be delivered as prescribed. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 16: 415-28. PMID 11001575 DOI: 10.1080/026567300416712 |
0.312 |
|
| 2000 |
Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ. Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and leukemia group B 9565 Journal of Clinical Oncology. 18: 2780-2787. PMID 10894879 DOI: 10.1200/Jco.2000.18.14.2780 |
0.363 |
|
| 2000 |
Anscher MS, Lee C, Hurwitz H, Tyler D, Prosnitz LR, Jowell P, Rosner G, Samulski T, Dewhirst MW. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer. International Journal of Radiation Oncology Biology Physics. 47: 719-724. PMID 10837956 DOI: 10.1016/S0360-3016(00)00473-9 |
0.354 |
|
| 1999 |
Marks L, Fitzgerald T, Laurie F, Glicksman A, Rosner G, Vredenburgh J, Shpall E, Crump M, Norton L, Peters W. 94 Preliminary analysis of radiotherapy data from CALGB 9082: variability of treatment fields for local/regional breast cancer and the impact of high dose chemotherapy on the ability to deliver radiation therapy International Journal of Radiation Oncology*Biology*Physics. 45: 195-196. DOI: 10.1016/S0360-3016(99)90112-8 |
0.306 |
|
| 1998 |
Lilenbaum RC, Miller AA, Batist G, Bernard S, Hollis DR, Rosner GL, Egorin MJ, Schilsky RL, Ratain MJ. Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: A cancer and leukemia group B study Journal of Clinical Oncology. 16: 3302-3309. PMID 9779705 DOI: 10.1200/Jco.1998.16.10.3302 |
0.407 |
|
| 1998 |
Venook AP, Egorin MJ, Rosner GL, Brown TD, Jahan TM, Batist G, Hohl R, Budman D, Ratain MJ, Kearns CM, Schilsky RL. Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and leukemia group B 9264 Journal of Clinical Oncology. 16: 1811-1819. PMID 9586895 DOI: 10.1200/Jco.1998.16.5.1811 |
0.378 |
|
| 1997 |
Rosner GL, Müller P. Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models Journal of Pharmacokinetics and Biopharmaceutics. 25: 209-233. PMID 9408860 DOI: 10.1023/A:1025784113869 |
0.303 |
|
| 1997 |
Müller P, Rosner GL. A Bayesian Population Model with Hierarchical Mixture Priors Applied to Blood Count Data Journal of the American Statistical Association. 92: 1279-1292. DOI: 10.1080/01621459.1997.10473649 |
0.322 |
|
| 1995 |
Gilbert CJ, Ohly KV, Rosner G, Peters WP. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation. Cancer. 76: 2330-7. PMID 8635039 DOI: 10.1002/1097-0142(19951201)76:11<2330::Aid-Cncr2820761122>3.0.Co;2-F |
0.355 |
|
| 1995 |
Fleming RA, Capizzi RL, Rosner GL, Oliver LK, Smith SJ, Schiffer CA, Silver RT, Peterson BA, Weiss RB, Omura GA. Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study. Cancer Chemotherapy and Pharmacology. 36: 425-30. PMID 7634384 DOI: 10.1007/Bf00686192 |
0.31 |
|
| 1995 |
Brizel DM, Rosner GL, Prosnitz LR, Dewhirst MW. Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases International Journal of Radiation Oncology, Biology, Physics. 32: 1121-1125. PMID 7607933 DOI: 10.1016/0360-3016(95)00106-9 |
0.314 |
|
| 1995 |
Cartee L, Petros WP, Rosner GL, Gilbert C, Moore S, Affronti ML, Hoke JA, Hussein AM, Ross M, Rubin P, Vredenburgh JJ, Peters WP. Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study Cytokine. 7: 471-477. PMID 7578986 DOI: 10.1006/Cyto.1995.0064 |
0.373 |
|
| 1995 |
Lilenbaum RC, Ratain MJ, Miller AA, Hargis JB, Hollis DR, Rosner GL, O'Brien SM, Brewster L, Green MR, Schilsky RL. Phase I study of paclitaxel and topotecan in patients with advanced tumors: A cancer and leukemia group B study Journal of Clinical Oncology. 13: 2230-2237. PMID 7545219 DOI: 10.1200/Jco.1995.13.9.2230 |
0.38 |
|
| 1994 |
Marks LB, Rosner GL, Prosnitz LR, Ross M, Vredenburgh JJ, Peters WP. The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local- regional radiotherapy for breast cancer Cancer. 74: 2964-2971. PMID 7954260 DOI: 10.1002/1097-0142(19941201)74:11<2964::Aid-Cncr2820741112>3.0.Co;2-X |
0.375 |
|
| 1994 |
Miller AA, Hargis JB, Lilenbaum RC, Fields SZ, Rosner GL, Schilsky RL. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: A cancer and leukemia group B study Journal of Clinical Oncology. 12: 2743-2750. PMID 7527456 DOI: 10.1200/Jco.1994.12.12.2743 |
0.361 |
|
| 1994 |
Rosner GL, Müller P. Pharmacodynamic analysis of hematologic profiles Journal of Pharmacokinetics and Biopharmaceutics. 22: 499-524. PMID 7473079 DOI: 10.1007/Bf02353792 |
0.347 |
|
| 1993 |
Lichtman SM, Ratain MJ, Echo DAV, Rosner G, Egorin MJ, Budman DR, Vogelzang NJ, Norton L, Schilsky RL. Phase I Trial of Granulocyte—Macrophage Colony-Stimulating Factor Plus High-Dose Cyclophosphamide Given Every 2 Weeks: a Cancer and Leukemia Group B Study Journal of the National Cancer Institute. 85: 1319-1326. PMID 8340944 DOI: 10.1093/Jnci/85.16.1319 |
0.388 |
|
| 1992 |
Marks LB, Halperin EC, Prosnitz LR, Ross M, Vredenburgh JJ, Rosner GL, Peters W. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥ 10 positive axillary lymph nodes International Journal of Radiation Oncology, Biology, Physics. 23: 1021-1026. PMID 1639635 DOI: 10.1016/0360-3016(92)90908-Z |
0.325 |
|
| 1992 |
Gillette SM, Dewhirst MW, Gillette EL, Thrall DE, Page RL, Powers BE, Withrow SJ, Rosner G, Wong C, Sim DA. Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 8: 309-20. PMID 1607736 DOI: 10.3109/02656739209021786 |
0.34 |
|
| 1992 |
Page RL, Macy DW, Ogilvie GK, Rosner GL, Dewhirst MW, Thrall DE, Withrow SJ, Mcentee MC, Cline JM, Heidner GL, Novotney CA, Gillette EL. Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma International Journal of Hyperthermia. 8: 187-197. PMID 1573308 DOI: 10.3109/02656739209021774 |
0.302 |
|
| 1992 |
Perfect JR, Klotman ME, Gilbert CC, Crawford DD, Rosner GL, Wright KA, Peters WP. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. The Journal of Infectious Diseases. 165: 891-7. PMID 1569339 DOI: 10.1093/Infdis/165.5.891 |
0.312 |
|
| 1992 |
Penta JS, Rosner GL, Trump DL. Choice of starting dose and escalation for phase I studies of antitumor agents Cancer Chemotherapy and Pharmacology. 31: 247-250. PMID 1464163 DOI: 10.1007/Bf00685555 |
0.347 |
|
| 1991 |
Keane TE, Rosner GL, Gingrich JR, Poulton SH, Walther PJ. The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer. The Journal of Urology. 146: 1418-24. PMID 1942313 DOI: 10.1016/S0022-5347(17)38127-2 |
0.372 |
|
| 1990 |
Keane TE, Rosner G, Donaldson JT, Norwood DL, Poulton SH, Walther PJ. Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers. The Journal of Urology. 144: 1004-9. PMID 2398547 DOI: 10.1016/S0022-5347(17)39647-7 |
0.348 |
|
| Show low-probability matches. |